arrow_back Back to App

Tianeptine and Analogues: New Controlled Substance Regulations

This act aims to add tianeptine and its derivatives to the list of controlled substances, meaning their production, distribution, and possession will be strictly regulated. This change is intended to protect public health by restricting access to substances with addictive potential similar to opioids. Citizens should be aware that possessing these substances without proper authorization will become illegal.
Key points
Tianeptine and its analogues will be added to Schedule III of the Controlled Substances Act.
The change will take effect 90 days after the act's enactment, making possession without proper authorization illegal thereafter.
The goal is to combat emerging threats from opioid-like substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7068
Sponsor: Rep. Panetta, Jimmy [D-CA-19]
Process start date: 2024-01-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

STAND Against Emerging Opioids Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7068.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-01-22.

What are the main provisions?

Key points include:

  • Tianeptine and its analogues will be added to Schedule III of the Controlled Substances Act.
  • The change will take effect 90 days after the act's enactment, making possession without proper authorization illegal thereafter.
  • The goal is to combat emerging threats from opioid-like substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Panetta, Jimmy [D-CA-19].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Courts and Law Security